SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,028.02 1,718.01
( 2.17%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

57,293.47 -3,784.43
(-6.20%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

432.144993

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

39.86

113828.97

EPS(TTM)

Face Value()

Div & Yield %

35.35

0.92

Back

mrf ltd

Cipla consolidated net profit declines 35.05% in the September 2026 quarter

Oct 27,2026

Net profit of Cipla declined 35.05% to Rs 877.54 crore in the quarter ended September 2026 as against Rs 1351.17 crore during the previous quarter ended September 2025. Sales declined 1.06% to Rs 7368.15 crore in the quarter ended September 2026 as against Rs 7447.42 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	7368.15	7447.42	-1
OPM %	18.83	25.44	-
PBDT	1522.20	2150.52	-29
PBT	1177.34	1853.53	-36
NP	877.54	1351.17	-35

81,028.02 1,718.01 ( 2.17%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

57,293.47 -3,784.43 (-6.20%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)